George F. Vande Woude
#175,092
Most Influential Person Now
George F. Vande Woude's AcademicInfluence.com Rankings
George F. Vande Woudebiology Degrees
Biology
#14502
World Rank
#18269
Historical Rank
Microbiology
#930
World Rank
#1023
Historical Rank
Download Badge
Biology
Why Is George F. Vande Woude Influential?
(Suggest an Edit or Addition)George F. Vande Woude's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Met, metastasis, motility and more (2003) (2460)
- Molecular cloning of a new transforming gene from a chemically transformed human cell line (1984) (924)
- Targeting MET in cancer: rationale and progress (2012) (837)
- Abnormal Centrosome Amplification in the Absence of p53 (1996) (813)
- The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs (1989) (647)
- Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes (1988) (591)
- Targeting MET in cancer: rationale and progress (2012) (548)
- Mechanism of met oncogene activation (1986) (518)
- Met receptor tyrosine kinase: enhanced signaling through adapter proteins (2000) (426)
- A closely linked genetic marker for cystic fibrosis (1985) (423)
- Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes * (1998) (349)
- Inactivation of Lrg-47 and Irg-47 Reveals a Family of Interferon γ–Inducible Genes with Essential, Pathogen-Specific Roles in Resistance to Infection (2001) (348)
- Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation (2003) (344)
- A novel germ line juxtamembrane Met mutation in human gastric cancer (2000) (340)
- Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP (2000) (265)
- The human met oncogene is related to the tyrosine kinase oncogenes (1985) (261)
- Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs (1989) (246)
- Meiotic initiation by the mos protein in Xenopus (1992) (239)
- Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus (1982) (220)
- Genomic instability and apoptosis are frequent in p53 deficient young mice (1997) (204)
- Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis (2002) (195)
- Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis (1996) (195)
- Down-regulation of MET, the receptor for hepatocyte growth factor (2001) (168)
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia (2012) (167)
- Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase (2002) (148)
- Expression of c-mos proto-oncogene transcripts in mouse tissues (1985) (135)
- Identification of a Novel GTPase, the Inducibly Expressed GTPase, That Accumulates in Response to Interferon γ* (1996) (133)
- Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis (2004) (130)
- Gene amplification and analysis (1986) (129)
- Evidence that MIG-6 is a tumor-suppressor gene (2007) (127)
- Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase (2001) (104)
- The ins and outs of p53 (2000) (89)
- Molecular cloning of Snyder-Theilen feline leukemia and sarcoma viruses: comparative studies of feline sarcoma virus with its natural helper virus and with Moloney murine sarcoma virus (1980) (87)
- Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor (2005) (73)
- Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells (2000) (62)
- Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment (2004) (57)
- Anthrax lethal factor causes proteolytic inactivation of mitogen‐activated protein kinase kinase (1999) (55)
- Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion (2005) (47)
- A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings (2009) (46)
- MEK Wars, a new front in the battle against cancer (1999) (42)
- Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor (1998) (41)
- An alternatively spliced form of Met receptor is tumorigenic (2006) (39)
- Cells transformed by certain strains of moloney sarcoma virus contain murine p60 (1977) (35)
- Ras Oncogene-Induced Sensitization to 1-β-d-Arabinofuranosylcytosine (1999) (33)
- Wee1-Regulated Apoptosis Mediated by the Crk Adaptor Protein in Xenopus Egg Extracts (2000) (32)
- Analysis of the transforming potential of the human homolog of mos (1986) (26)
- A Mouse Model of Activating Met Mutations (2005) (25)
- Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling (1999) (23)
- Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms (2017) (23)
- Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression (2017) (20)
- Oncogenes and viral genes (1984) (19)
- Reanalysis of Cancer Drugs (2004) (18)
- Zinc finger E‐box binding homeobox‐1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger‐1 (NHE1) (2017) (17)
- Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors (2008) (15)
- Decreased fibronectin expression in Met/HGF-mediated tumorigenesis (1998) (15)
- 556 POSTER MetMAb significantly enhances anti-tumor activity of anti-VEGF and/or erlotinib in several animal tumor models (2008) (13)
- The inactivation of foot-and-mouth disease virus at ionic-strength dependent isoelectric points. (1967) (12)
- On the loss of Mos (1994) (11)
- Cell cycle control and early embryogenesis: Xenopus laevis maturation and early embryonic cell cycles (1994) (11)
- A closely linked genetic marker for cystic fibrosis (1986) (9)
- Developmental biology: An arresting activity (2002) (9)
- Molecular cloning of the intronless EJ ras oncogene using a murine retrovirus shuttle vector (1986) (8)
- [29] Microinjection into Xenopus oocytes (1995) (7)
- The ins and outs of p 53 (6)
- Activation of a C-type virus from the human carcinoma cell line HBT-3 by iododeoxyuridine and testosterone (1974) (6)
- Grappling with metastatic risk: Bringing molecular imaging of Met expression toward clinical use (2002) (6)
- Metastatic melanoma and matrix metalloproteinases (2003) (4)
- LongTerminal Repeat Enhancement ofv-mos Transforming Activity: Identification ofEssential Regions (1983) (4)
- MIG-6 and SPRY2 in the Regulation of Receptor Tyrosine Kinase Signaling: Balancing Act via Negative Feedback Loops (2013) (4)
- Immunogold labeling of oncogenic and tumor related proteins (1995) (4)
- Distinct developmental patterns of cmos protooncogene expression in female and male mouse germ cells ( mammalian development / gene expression / oogenesis / in situ hybridization ) (3)
- The influence of the host cell, ionic strength and chymotrypsin on foot-and-mouth disease virus electrophoretic mobility (2005) (3)
- The MET Receptor Family (2015) (3)
- Met Activation and Carcinogenesis (2018) (3)
- Moloney sarcoma virus a model for transformation by endogenous cellular genes (1982) (3)
- Purification of Herpesvirus saimiri and properties of the viral DNA (2005) (3)
- Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma (ccRCC) and its association with PD-L1 expression. (2017) (2)
- Abstract 3022: MET and ERBB2 are coexpressed in ERBB2+ breast cancers and contribute to innate resistance. (2013) (2)
- Changes in protein and nucleic acid metabolism in baby hamster kidney cells infected with foot-and-mouth disease virus (2005) (2)
- HumanRecipient Cell forOncogene Transfection Studies (1987) (2)
- How anthrax kills [1] (multiple letters) (1998) (2)
- Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition (2011) (2)
- Evidence for a single structural polypeptide in foot-and-mouth disease virus (2005) (2)
- LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY (2012) (1)
- Electrophoresis . Theory, Methods, and Applications. Vol. 2. Milan Bier, Ed. Academic Press, New York, 1967. xviii + 553 pp., illus. $21 (1968) (1)
- Translation products of foot-and-mouth disease virus-infected baby hamster kidney cells (2005) (1)
- Abstract 326: Aneuploidy-driven clonal diversification underlies tumor phenotype switching (2012) (1)
- Characterization of natural killer (NK) cell activating receptor NKG2D ligands on pediatric solid and hematologic malignancies (2005) (1)
- Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia. (2010) (1)
- Mos, Meiosis and Cellular Transformation (1996) (1)
- Abstract 2167: Strengthening anti-cancer effects on non-small cell lung carcinoma by dual blockage of MET and EGFR in a context-dependent manner. (2013) (1)
- Cloning Retroviruses: Retrovirus Cloning? (1981) (1)
- BI-14GENOMIC PROFILING OF A PREDICTIVE SIGNATURE FOR MET-TARGETED THERAPY IN GLIOBLASTOMA (2014) (0)
- Abstract 3256: Investigating the intrinsic signaling differences in MET- and ERBB2-driven breast cancers (2010) (0)
- Abstract 2927: Breast tumor kinase (Brk/PTK6) mediates hypoxia/HIF-1α-associated breast cancer progression. (2013) (0)
- - Mos: Mos gene product (vertebrates) (1995) (0)
- TITERING AND AMPLIFICATION OF FINAL (2017) (0)
- Abstract 2896: Genomic determinants and signature of MET-targeted therapy in glioblastoma. (2013) (0)
- Abstract LB-015: Differential therapeutic responses of MET oncogenic activations to Met kinase inhibitor and neutralizing antibody (2018) (0)
- Abstract 4092: Cancer-type regulation of MIG-6 expression by 5-Aza-2′-deoxycytidine and Trichostatin A (2012) (0)
- DNA sequence of an Immediate-early gene ( IE mRNAS ) of herpes simplex rims type I (2005) (0)
- Mos Proto-Oncogene and Cell Cycle Regulation (1994) (0)
- Abstract 2316: Epithelial to mesenchymal transition: Interplay between E-Cadherin and HGF/SF-Met signaling (2010) (0)
- British Association for Cancer Research/ 'Association of Cancer Physicians/British Society for Cell Biology/Royal Society of Medicine (Oncology Section) Joint Winter Meeting on `Cell cycle control and cellular proliferation' (Incorporating the Gordon Hamilton-Fairley Memorial Lecture and the Alexand (1993) (0)
- Comprar Advances in Cancer Research Volume 100 | George F. Vande Woude | 9780123743589 | Academic Press (2008) (0)
- Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor (2002) (0)
- Anthrax toxin receptor (ANTXR1)/TEM 8 expression and sensitivity to protective antigen plus lethal factor. (2004) (0)
- Abstract 3946: Chromosome instability drives phenotypic switching to metastasis (2017) (0)
- Cis Regulatory Control of mos Oncogene Expression (1987) (0)
- Abstract 4864: Targeting MET and ERBB2 signaling in aggressive breast cancers (2012) (0)
- Protein-Analysis Technique: Electrophoresis . Theory, Methods, and Applications. Vol. 2. Milan Bier, Ed. Academic Press, New York, 1967. xviii + 553 pp., illus. $21. (1968) (0)
- Abstract LB-305: Why two are better than one: Suppression of carcinoma cell growthin vitroand in human HGF/SF transgenic SCID by inhibitors of MET (SGX523) and EGFR (erlotinib) (2010) (0)
- Hepatocyte Growth Factor Promotes Cancer Cell Migration andAngiogenic Factors Expression : APrognosticMarker of Human Esophageal Squamous Cell Carcinomas (2005) (0)
- Abstract LB-39: Phenotypic switching and molecular anatomy of malignant progression (E-M-T/M-E-T). (2011) (0)
- TWO REGIONS OF THE MOLONEY LEUKEMIA VIRUS GENOME ARE REQUIRED FOR EFFICIENT TRANSFORMATION BY src/sarc (1980) (0)
- Met signaling and malignant progression (2008) (0)
- The Multiple Roles of Mos during Meiosis (1999) (0)
- Abstract LB-118: 17AAG, through hydrophobic binding, targets mitochondrial VDAC and inhibits cell invasion (2010) (0)
- Herpes Simplex Virus Superinfection of Mouse Cells Chronically Infected with Rausher Leukemia Virus (1974) (0)
- Letter from George F. Vande Woude, National Institutes of Health to Harold Varmus (1980) (0)
- Chapter 8 MIG-6 and SPRY 2 in the Regulation of Receptor Tyrosine Kinase Signaling : Balancing Act via Negative Feedback Loops (2017) (0)
- Patients with Late-stage Nasopharyngeal Carcinoma Met Protein Expression Level Correlates with Survival in Updated (2002) (0)
- Anthrax Toxins, Mitogen-Activated Protein Kinase Pathway, and Melanoma Treatment (2002) (0)
- mos Proto-Oncogene Product and Cytostatic Factor (1991) (0)
- Anthrax tumor toxin (LeTx) selectively kills B-RAF mutant melanomas (2005) (0)
- Advances in Brief Ras Oncogene-Induced Sensitization to 1-bD-Arabinofuranosylcytosine 1 (1999) (0)
- Therapeutic implications for acquired resistance and heart toxicity using targeted therapy to ErbB2 (2006) (0)
- Advances in Cancer Research (1936) (0)
- Macrophage Stimulating 1 Receptor (2011) (0)
- Identification of aMet-Binding Peptide from a Phage Display Library (2007) (0)
- Abstract LB-223: Dissecting the therapeutic determinants of MET inhibition in Glioblastoma: HGF-autocrine loop predicts sensitivity to MET inhibitor (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With George F. Vande Woude?
George F. Vande Woude is affiliated with the following schools:
